Eculizumab, a monoclonal antibody, is indicated for the treatment of two rare and life-threatening conditions: Paroxysmal ...

A decision to approve new medicines to treat Duchenne muscular dystrophy and a rare life-threatening blood disease for use in ...

Analysts at Jefferies have previously said that iptacopan could hit $3.6 billion in peak annual sales if it gets approved for all its target indications, which along with PNH include atypical ...

The first-in-class therapy – a targeted factor B inhibitor – was able to "substantially" reduce the destruction of red blood cells (haemolysis) that occurs in PNH when used over 12 weeks as a ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Ever wondered why that one friend gets the stomach flu almost every year, while the rest of your friends are totally fine? Or why your partner never seems to contract the illness, even when you do?

The Press and Public Relations Coordination of the National Police of Haiti (PNH) announces that this Friday, January 10, 2025 at 9:00 a.m., the graduation ceremony of the 34th promotion of the PNH ...

Prime Minister Alix Didier Fils-Aimé participated in the graduation ceremony of the 34th promotion "Vertières" of the Haitian National Police (PNH) organized at the National Police School on the ...

Background Thrombocytosis can follow surgery and has occasionally been observed after major orthopaedic surgery. The aim of the present study was to ascertain the platelet count (PLTC) change in ...

The post TFSA: Here’s How to Bump Up Your Contribution for 2025 appeared first on The Motley Fool Canada. RBC (TSX: RY) (NYSE: RY) today announced it has partnered with Cohere, a leader in security ...

CHICAGO (WLS) -- The countdown begins! Wednesday, Nov. 20, marks 56 days until the 11th annual ABC 7 Great Chicago Blood Drive on Jan. 15 and 16, offering seven donation locations around the ...

BACKGROUND: Both unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) are approved for venous thromboembolism (VTE) prophylaxis. Which agent is superior remains controversial ...